x

Search for a clinical trial

* (*) mandatory field

32 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

GERMANY

Baden-Württemberg
FREIBURG

GERMANY

Baden-Württemberg
FREIBURG

Ongoing trial
Funded by an IRDiRC memberAn Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy (Phase III) - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

GERMANY

Baden-Württemberg
FREIBURG

Funded by an IRDiRC memberA Phase 3 Efficacy and Safety Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy - DE - Completed
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

GERMANY

Baden-Württemberg
FREIBURG

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberA Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

GERMANY

Nordrhein-Westfalen
ESSEN

ITALY

LAZIO
ROMA

Funded by an IRDiRC memberAn Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy (Phase III) - IT
IRCCS Ospedale Pediatrico Bambino Gesù
Unità di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

SPAIN

Comunidad Valenciana
VALENCIA

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

BELGIUM

VLAAMS BRABANT
LEUVEN

A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
University Hospitals Leuven - Gasthuisberg
Reference Centre for NeuroMuscular Diseases - UZLeuven

BELGIUM

VLAAMS BRABANT
LEUVEN

A Phase 2b Extension Study of Ataluren (PTC124) in Subjects With Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy.
University Hospitals Leuven - Gasthuisberg
Reference Centre for NeuroMuscular Diseases - UZLeuven

ITALY

LAZIO
ROMA

A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
IRCCS Ospedale Pediatrico Bambino Gesù
Unità di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare

SWEDEN

Stockholms läns landsting
STOCKHOLM

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Multinational clinical trial(s)